Last reviewed · How we verify

Immediate spa treatment

Association Francaise pour la Recherche Thermale · Phase 3 active Small molecule

Immediate spa treatment is a Small molecule drug developed by Association Francaise pour la Recherche Thermale. It is currently in Phase 3 development for Osteoarthritis and joint pain management, Musculoskeletal recovery and rehabilitation.

Immediate spa treatment uses thermal mineral water and heat exposure to promote physiological relaxation and tissue healing.

Immediate spa treatment uses thermal mineral water and heat exposure to promote physiological relaxation and tissue healing. Used for Osteoarthritis and joint pain management, Musculoskeletal recovery and rehabilitation.

Likelihood of approval
59.3% vs 58.3% industry baseline
If approved by FDA: likely 2028–2030
Steps remaining: NDA/BLA submission
Confidence: High
Why this estimate
  • Baseline phase 3 → approval rate +58.3pp
    Industry-wide phase 3 drugs reach approval ~58.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
  • Immunology slight uplift +1.0pp
    Mature endpoint landscape (ACR, DAS28, PASI) makes immunology approvals slightly more predictable.
Predicted approval windows by jurisdiction (conditional on FDA approval)
Regulator Country Likely year Lag vs FDA
FDA US 2028–2030
EMA EU 2029–2031 +0.7 yr
MHRA GB 2029–2031 +0.7 yr
Health Canada CA 2029–2032 +0.9 yr
TGA AU 2029–2032 +1.2 yr
PMDA JP 2029–2032 +1.5 yr
NMPA CN 2030–2033 +2.3 yr
MFDS KR 2029–2032 +1.4 yr
CDSCO IN 2029–2033 +1.8 yr
ANVISA BR 2030–2033 +2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic nameImmediate spa treatment
SponsorAssociation Francaise pour la Recherche Thermale
ModalitySmall molecule
Therapeutic areaRheumatology / Musculoskeletal / Wellness
PhasePhase 3

Mechanism of action

Spa treatments leverage the therapeutic properties of naturally heated mineral-rich waters combined with immersion, massage, and rest to reduce inflammation, improve circulation, and promote musculoskeletal recovery. The mechanism involves both the chemical composition of thermal waters (minerals such as sulfur, silica, and trace elements) and the physical effects of heat and buoyancy on the body. This approach is classified as a non-pharmacological intervention within thermal medicine.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Immediate spa treatment

What is Immediate spa treatment?

Immediate spa treatment is a Small molecule drug developed by Association Francaise pour la Recherche Thermale, indicated for Osteoarthritis and joint pain management, Musculoskeletal recovery and rehabilitation.

How does Immediate spa treatment work?

Immediate spa treatment uses thermal mineral water and heat exposure to promote physiological relaxation and tissue healing.

What is Immediate spa treatment used for?

Immediate spa treatment is indicated for Osteoarthritis and joint pain management, Musculoskeletal recovery and rehabilitation.

Who makes Immediate spa treatment?

Immediate spa treatment is developed by Association Francaise pour la Recherche Thermale (see full Association Francaise pour la Recherche Thermale pipeline at /company/association-francaise-pour-la-recherche-thermale).

What development phase is Immediate spa treatment in?

Immediate spa treatment is in Phase 3.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing